The technology used to develop the Gamaleya Microbiology Research Centre’s vaccine against COVID-19 was earlier practiced while creating vaccines against other diseases, therefore there is no need to postpone registration, Nikolay Briko, the Russian Health Ministry’s chief epidemiologist, told Sputnik on Tuesday.
“I do not understand at all why this issue has emerged. If we are talking about the Gamaleya Centre’s vaccine, it has not appeared out of nowhere. The centre has been conducting research in this area for over 10 years, it has created vaccines against Ebola and the Middle East respiratory syndrome. The same adenovirus-based technology was used during the creation of the COVID-19 vaccine, it is not subject to any review or delay, since the technology has already been practiced”, Briko said.
Continue reading https://sptnkne.ws/DrH7